Moreover, upregulation of Mbp and Ng2, as well as a significant reduction of Cd74 and Erk1/2, was confirmed in SCH772984-treated primary neuronal cultures from control and AD KI mice (Fig. 4i and j). This evidence concerns the gene MAPK3 and Alzheimer disease.